Literature DB >> 16865234

Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system.

A H M Nurun Nabi1, Ayano Kageshima, Mohammad Nasir Uddin, Tsutomu Nakagawa, Enoch Y Park, Fumiaki Suzuki.   

Abstract

The rat recombinant renin/prorenin receptor (AB188298 in DDJB), which conjugated with FLAG epitope in its N-terminus, was expressed in a baculovirus expression system. The recombinant receptor, prepared from the cytoplasmic fraction of the insect cells, was identified by Western blotting using anti-FLAG antibody. Prorenin as well as renin bound to the receptor with different binding affinities. Their Kd values were estimated at 8.0 and 20 nM, respectively. The amounts of prorenin and renin bound to the immobilized receptors were 1.0 and 0.2 pmole, respectively. The prorenin bound to the receptor had renin activity and the renin kept the activity at similar level to that before the binding. The Km of their complexes was the same at 3.3 microM when sheep angiotensinogen was used as the substrate. Their Vmax values were 5.5 and 10 nM.h(-1), respectively. The molecular activities of prorenin and renin bound to the receptor were 1.1 and 10 h(-1), respectively. From these findings, rat prorenin as well as renin was indicated to bind to the recombinant receptor and express the enzymatic activity in vitro.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865234

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  40 in total

1.  Renin and cardiovascular disease: Worn-out path, or new direction.

Authors:  Gaurav Alreja; Jacob Joseph
Journal:  World J Cardiol       Date:  2011-03-26

Review 2.  Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease.

Authors:  Ravi Nistala; Yongzhong Wei; James R Sowers; Adam Whaley-Connell
Journal:  Transl Res       Date:  2009-01-23       Impact factor: 7.012

Review 3.  Prorenin/renin receptor, signals, and therapeutic efficacy of receptor blocker in end-organ damage.

Authors:  Tadashi Inagami; Atsuhiro Ichihara
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

4.  Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression.

Authors:  Huifang Cheng; Xiaofeng Fan; Gilbert W Moeckel; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2011-07       Impact factor: 10.121

5.  Prostaglandin E-prostanoid4 receptor mediates angiotensin II-induced (pro)renin receptor expression in the rat renal medulla.

Authors:  Fei Wang; Xiaohan Lu; Kexin Peng; Yaomin Du; Shu-Feng Zhou; Aihua Zhang; Tianxin Yang
Journal:  Hypertension       Date:  2014-05-27       Impact factor: 10.190

Review 6.  Renin and prorenin receptor in hypertension: what's new?

Authors:  Genevieve Nguyen
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

7.  Aliskiren reduces the release of soluble (pro)renin receptor from human umbilical vein endothelial cells.

Authors:  Shinji Yamashita; Kazal Boron Biswas; A H M Nurun Nabi; Tsutomu Nakagawa; Fumiaki Suzuki; Akio Ebihara
Journal:  Biomed Rep       Date:  2018-07-05

8.  Soluble Prorenin Receptor Increases Blood Pressure in High Fat-Fed Male Mice.

Authors:  Eva Gatineau; Ming C Gong; Frédérique Yiannikouris
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

9.  Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.

Authors:  Adam Whaley-Connell; Ravi Nistala; Javad Habibi; Melvin R Hayden; Rebecca I Schneider; Megan S Johnson; Roger Tilmon; Nathan Rehmer; Carlos M Ferrario; James R Sowers
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-09

10.  (Pro)Renin receptor regulates potassium homeostasis through a local mechanism.

Authors:  Chuanming Xu; Aihua Lu; Hong Wang; Hui Fang; Li Zhou; Peng Sun; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.